Formononetin, an extract used in clinical preparations, attenuates nephrotoxicity‐stimulated AKI by regulating organic‐cation‐transporter‐2, p53, and the PPARα/Nrf2/HO‐1/NQO1 pathway.39, 51, 52. Here, NQO1 is linked to acute kidney injury.